Quailty of life and Parkinson’s disease: Philippine translation and validation of the Parkinson’s disease questionnaire
Objective: This study translated PDQ-39 into the Filipino language as the Philippine-PDQ-39 (P-PDQ-39), and used it to assess the quality of life of Filipino patients…Assessing hemifacial spasm: The HFSG scale
Objective: To create and validate an objective assessing tool to diagnose and monitor HFS and the efficacy of its treatments. Background: Hemifacial spasm (HFS), is…Factors affecting quality of life in patients with Parkinson´s disease: Motor vs non-motor symptoms. Results from the COPPADIS Study Cohort
Objective: To identify factors related to a worse health-related and global perceived quality of life (QoL) in a cohort of Parkinson´s disease (PD) patients and…A Psychometric Analysis of the MDS UPDRS-II and III in Early Parkinson’s disease: Do the Numbers Add Up?
Objective: Our objective was to explore the psychometric evidence for the use of the Movement Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) part II…Analysis of the electromyographic profile of a subject with spasticity during the lateral reactive postural control test
Objective: To compare the temporal profile and the level of muscular activity of a subject with Stroke and a healthy subject, as well as to…The International Parkinson and Movement Disorder Society Non-Motor Scale (MDS-NMS) for Parkinson’s Disease: Preliminary results from an international validation
Objective: To provide an update on the ongoing international validation programme of an expanded, refined and improved scale for the assessment of non-motor symptoms (NMS)…Validation of a performance-based assessment of functional ability related to cognition in Parkinson’s disease
Objective: Validate the University of California San Diego Performance-Based Skills Assessment (UPSA) in Parkinson's disease (PD) Background: Diagnostic criteria for PD dementia (PDD) require significant…Sample size estimation for clinical trials in de novo Parkinson’s disease (PD): Results from the Parkinson’s Progression Markers Initiative (PPMI) Study
Objective: To use clinical and biological data from PPMI to estimate sample size for disease modification studies in de novo PD Background: One barrier to…Classification of neurocognitive impairment in Spanish speaking Parkinson’s disease patients
Objective: To examine differences between United States (US) and Latin American (LA) norms classifying cognitive impairment using standardized neuropsychological measures to assess cognition in Parkinson’s…Five year longitudinal change in the MDS-UPDRS scores in early Parkinson’s disease participants: Results from the PPMI Study
Objective: To determine the longitudinal change in the Movement Disorder Society –Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) in Parkinson’s disease (PD) participants who were untreated…
- « Previous Page
- 1
- …
- 23
- 24
- 25
- 26
- 27
- …
- 32
- Next Page »